Trokendi Xr Capsule, Extended Release
Pricing Report NDC 17772-101-15

Latest NADAC: $9.88456 per EA · Effective Jan 01, 2020 · Est. package price $296.54 (30 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Trokendi Xr (NDC 17772-101-15) is $9.88456 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 01, 2020.

As a a human prescription drug provided by Supernus Pharmaceuticals, Inc., this medication is distributed in a 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.88456
Per EA

Effective Date
Jan 01, 2020
Billable Units
30 EA
Estimated Package Price
$296.54
Data Status
As of Mar 25, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2013, the NADAC wholesale price for (NDC ) has moved within a range of $5.31533 to $13.29949 per EA. Over this 12 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.3153 - $13.2995
Market Volatility
150.21% Variance
Latest Trend
8.00%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 01, 2026 $13.29949 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jul 01, 2026 $13.29949 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jul 01, 2026 $13.29949 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jun 17, 2026 $12.31435 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $12.32219 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $12.35021 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $12.35097 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $12.37796 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 01, 2025 $12.42048 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 01, 2025 $12.42048 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 01, 2025 $12.42048 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Oct 01, 2025 $12.42048 EAC/I - Chain or Independent PharmacyCode 4B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026